Healthcare stocks were mostly higher Friday with the NYSE
Healthcare Sector Index gaining about 0.5% while shares of
healthcare companies in the S&P 500 were up about 0.1% as a
In company news, Agilent Technologies Inc. (
) slid Friday, with shares of the bio-analysis and electronic
measurement company falling to a two-month low after it reduced its
FY14 guidance and fiscal Q1 sales missed analyst forecasts by a
Profit for the three months ended Jan. 31 was $0.67 per share,
up from a $0.63 gain in the year-ago period and beating analyst
estimates by $0.01 per share. Sales were little changed from last
year at $1.68 million, trailing the Thomson Reuters consensus by
$14 million, or about 0.8%.
The company last night also lowered the top end of its FY14
profit projections by $0.17 to a new range of $2.96 to $3.16 per
share, now lagging the analyst view by at least $0.03 per
Separately Friday, A announced positive findings from a
multi-center study in France of its HER2 IQFISH pharmDx diagnostics
tool, stating the quick test for breast cancer provides "excellent
quality signals without any background staining."
A shares were down about 7% at $55.81 each in recent trade,
slipping to an intra-day low of $5.37 a share. The stock has a
52-week range of $40.19 to $61.22 a share.
In other sector news,
(+) LCAV, (+25.8%) Climbs to new 52-week high after agreeing to
$106.4 mln buyout from PhotoMedex (
). LCAV shareholders will receive $5.37 a share - a 34% premium
over Wednesday's close. Deal seen adding to PHMD FY14 earning.
(-) ADAT, (-12.6%) Narrows net loss by 36% from the same quarter
last year, recording $0.07 per share loss in fiscal Q2. Revenue
increases 39% over year-ago period to $1.5 million. No analyst
estimates were available for comparison.